Related Experiment Video
Updated: Jul 16, 2026

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D
Published on: December 9, 2022
Dysoxylins A-D, tetranortriterpenoids with potent anti-RSV activity from Dysoxylum gaudichaudianum
Jian Lu Chen1, Michael R Kernan, Shivanand D Jolad
1Shaman Pharmaceuticals, South San Francisco, California 94080, USA.
Abstract:
Four new compounds, belonging to the tetranortriterpenoid family, named dysoxylins A-D (1-4), isolated from Dysoxylum gaudichaudianum, were found to exhibit potent antiviral activity against respiratory syncytial virus (RSV). These structures were determined by NMR spectroscopy and mass spectrometry and were shown to have anti-RSV EC50 activities in the range 1.0-4.0 microg/mL in cytopathic effect inhibition and plaque reduction assays.
Related Concept Videos
Respiratory Syncytial Virus Disease
Diphtheria
Antiviral Nucleoside Inhibitors
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Inhibitors Of Virion Release
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
